Change of Fibroblast Growth Factor 21 Level Correlates with the Severity of Diabetic Sensory Polyneuropathy After Six-Week Physical Activity

Overview

Journal Rev Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2024 Jul 30

PMID 39077619

Authors

Agnes Molnar

Anita Szentpeteri

Hajnalka Lorincz

Ildiko Seres

Mariann Harangi

Zoltan Balogh

Peter Kempler

Gyorgy Paragh

Ferenc Sztanek

Affiliations

Soon will be listed here.

Abstract

Background: Diabetic neuropathy (DN) is a very frequent microvascular complication of type 2 diabetes mellitus (T2DM). Obesity and physical inactivity are well-known risk factors for T2DM. Fibroblast growth factor 21 (FGF21) is a liver-secreted hormone with several beneficial effects on obesity-related metabolic disorders. We aimed to investigate the effect of short-term physical activity on the levels of FGF21, and its correlation with the severity of peripheral sensory polyneuropathy in T2DM patients.

Methods: Thirty patients with DN were enrolled in the study, compared to age- and gender-matched controls. We conducted a six-week aerobic training program, which meant treadmill and cycle ergometers three times a week. Anthropometric and laboratory parameters were measured for each patient before and after intervention. Serum levels of FGF21, TNF-alpha, irisin, leptin and adiponectin were measured by ELISA. The sensory perception threshold (CPT) was quantitatively measured using Neurometer®.

Results: We found significant decreases in BMI, waist circumference, HbA1c and TNF-alpha levels. From baseline to six-week follow-up, FGF21 levels were significantly increased in DN patients. Significant negative correlations were shown between the changes in FGF21 levels and BMI, between changes in FGF21 and the improvement of CPT values, and between the changes in FGF21 and TNF-alpha levels. There was no difference in irisin, adiponectin and leptin levels in DN patients after aerobic training program.

Conclusions: The physical activity may increase the level of FGF21 in T2DM patients with neuropathy. Our results highlight the importance of regular physical activity in the treatment of diabetic neuropathy.

Citing Articles

Polyneuropathy in systemic sclerosis: exploring the causes and biomarkers.

Ivanova K, Zolovs M, Blennow K, Zetterberg H, Kurjane N, Kenina V Front Med (Lausanne). 2024; 11:1412706.

PMID: 39156689 PMC: 11329926. DOI: 10.3389/fmed.2024.1412706.

Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity.

Lorincz H, Somodi S, Ratku B, Harangi M, Paragh G Metabolites. 2023; 13(2).

PMID: 36837889 PMC: 9967669. DOI: 10.3390/metabo13020270.

References

Pekkala S, Wiklund P, Hulmi J, Ahtiainen J, Horttanainen M, Pollanen E . Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health?. J Physiol. 2013; 591(21):5393-400. PMC: 3936375. DOI: 10.1113/jphysiol.2013.263707. View

Khalafi M, Alamdari K, Symonds M, Nobari H, Carlos-Vivas J . Impact of acute exercise on immediate and following early post-exercise FGF-21 concentration in adults: systematic review and meta-analysis. Hormones (Athens). 2020; 20(1):23-33. DOI: 10.1007/s42000-020-00245-3. View

Kalkan O, Aktas O, Surmeneli Y, Alver A, Ozcan M, Sahin Z . Does irisin has neuroprotective effect against diabetes induced neuropathy in male rats?. Arch Physiol Biochem. 2020; 129(2):439-448. DOI: 10.1080/13813455.2020.1835985. View

Ma X, Qin J, Li H, Yan X, Zhao Y, Zhang L . Role of Exercise Activity in Alleviating Neuropathic Pain in Diabetes via Inhibition of the Pro-Inflammatory Signal Pathway. Biol Res Nurs. 2018; 21(1):14-21. DOI: 10.1177/1099800418803175. View

Jin L, Lin Z, Xu A . Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk. Diabetes Metab J. 2016; 40(1):22-31. PMC: 4768047. DOI: 10.4093/dmj.2016.40.1.22. View

Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V . Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 2007; 5(6):415-25. DOI: 10.1016/j.cmet.2007.05.003. View

Nadi M, Bambaeichi E, Marandi S . Comparison of the effect of two therapeutic exercises on the inflammatory and physiological conditions and complications of diabetic neuropathy in female patients. Diabetes Metab Syndr Obes. 2019; 12:1493-1501. PMC: 6708387. DOI: 10.2147/DMSO.S206454. View

Matos M, Mendes R, Silva A, Sousa N . Physical activity and exercise on diabetic foot related outcomes: A systematic review. Diabetes Res Clin Pract. 2018; 139:81-90. DOI: 10.1016/j.diabres.2018.02.020. View

Colberg S, Sigal R, Yardley J, Riddell M, Dunstan D, Dempsey P . Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care. 2016; 39(11):2065-2079. PMC: 6908414. DOI: 10.2337/dc16-1728. View

10.

Mashili F, Austin R, Deshmukh A, Fritz T, Caidahl K, Bergdahl K . Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes Metab Res Rev. 2011; 27(3):286-97. DOI: 10.1002/dmrr.1177. View

11.

Moreno-Navarrete J, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F . Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013; 98(4):E769-78. DOI: 10.1210/jc.2012-2749. View

12.

Staiger H, Keuper M, Berti L, de Angelis M, Haring H . Fibroblast Growth Factor 21-Metabolic Role in Mice and Men. Endocr Rev. 2017; 38(5):468-488. DOI: 10.1210/er.2017-00016. View

13.

Berglund E, Vianna C, Donato Jr J, Kim M, Chuang J, Lee C . Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J Clin Invest. 2012; 122(3):1000-9. PMC: 3287225. DOI: 10.1172/JCI59816. View

14.

Lin Z, Pan X, Wu F, Ye D, Zhang Y, Wang Y . Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice. Circulation. 2015; 131(21):1861-71. PMC: 4444420. DOI: 10.1161/CIRCULATIONAHA.115.015308. View

15.

Schamarek I, Herder C, Nowotny B, Carstensen-Kirberg M, Strassburger K, Nowotny P . Adiponectin, markers of subclinical inflammation and nerve conduction in individuals with recently diagnosed type 1 and type 2 diabetes. Eur J Endocrinol. 2016; 174(4):433-43. DOI: 10.1530/EJE-15-1010. View

16.

Kim H, So B, Choi M, Kang D, Song W . Resistance exercise training increases the expression of irisin concomitant with improvement of muscle function in aging mice and humans. Exp Gerontol. 2015; 70:11-7. DOI: 10.1016/j.exger.2015.07.006. View

17.

Fon Tacer K, L Bookout A, Ding X, Kurosu H, John G, Wang L . Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol Endocrinol. 2010; 24(10):2050-64. PMC: 2954642. DOI: 10.1210/me.2010-0142. View

18.

Holland W, Adams A, Brozinick J, Bui H, Miyauchi Y, Kusminski C . An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab. 2013; 17(5):790-7. PMC: 3667496. DOI: 10.1016/j.cmet.2013.03.019. View

19.

Vazquez-Vela M, Torres N, Tovar A . White adipose tissue as endocrine organ and its role in obesity. Arch Med Res. 2008; 39(8):715-28. DOI: 10.1016/j.arcmed.2008.09.005. View

20.

Jafarnezhadgero A, Mamashli E, Granacher U . An Endurance-Dominated Exercise Program Improves Maximum Oxygen Consumption, Ground Reaction Forces, and Muscle Activities in Patients With Moderate Diabetic Neuropathy. Front Physiol. 2021; 12:654755. PMC: 8044992. DOI: 10.3389/fphys.2021.654755. View